The Retinal Ghost Laminate is a biochemically-bonded photoreceptor overlay applied directly to the surface of the cornea and retina via a controlled enzyme deposition process. A suspension of synthetic rhodopsin analogs and piezoelectric nanofilaments is introduced through a series of eye drops administered over seventy-two hours, during which the laminate self-assembles into a semi-permanent optical augmentation layer. Once cured, it interfaces with the user's existing visual cortex pathways without requiring surgical implantation, making it one of the few augmentations that leaves no hardware signature on standard bioscan sweeps.

What distinguishes the Retinal Ghost Laminate from competing optical augments is its passive persistence — the laminate requires no power draw, no wireless handshake, and no maintenance cycle. It operates entirely through biochemical signal transduction, translating photon input across an extended spectrum into neurochemical impulses the brain interprets as enhanced vision. Users gain low-light amplification, ultraviolet edge detection, and a subtle depth-contrast mode that makes structural outlines and silhouettes pop against cluttered backgrounds. The trade-off is that the laminate cannot be switched off; users must adapt to persistent enhanced perception, which causes disorientation in high-glare environments until neurological habituation sets in over several weeks.

The laminate was originally developed for deep-shaft agricultural inspectors working in bioluminescent fungal farms under Ironclad Agrisystems contract, where artificial lighting is minimal and UV markers are used to track crop health. It has since migrated heavily into the courier underground, the investigative journalism circuit, and among long-term squatters navigating unlit infrastructure corridors. Corporate security consultants prize it precisely because it evades augmentation disclosure laws — the laminate reads as a benign ocular treatment on most medical scanners.